\n<\/p>\n
Halep tested positive for roxadustat, an anti-anaemia drug which stimulates the production of red blood cells in the body.<\/p>\n
In May 2023, Halep was handed a second charge by the International Tennis Integrity Agency (ITIA), this time for irregularities in her athlete biological passport (ABP).<\/p>\n
An independent report, instigated by the ITIA, ruled Halep had “intentionally” doped and handed out a four-year ban.<\/p>\n
Halep appealed against the decision and on Tuesday it was announced her case was partially upheld, with Cas ruling Halep “on the balance of probabilities” had not taken roxadustat intentionally.<\/p>\n
The charge relating to the discrepancies in her athlete biological passport was dismissed by Cas.<\/p>\n
Halep’s suspension was cut to nine months and backdated to the start of her provisional suspension in October 2022, meaning she is able to return to competition in the coming weeks.<\/p>\n
Halep said the ruling was a “pivotal moment” which provided “clarity”.<\/p>\n
If the original suspension until October 2026 had stood, she would have just turned 35 when allowed to return.<\/p>\n
“In the midst of this challenging journey, my unwavering belief in the integrity of the truth and in the principles of justice has been my beacon,” she said.<\/p>\n
“Looking forward, I am eager to turn this page and rejoin the tour with renewed vigour and an invigorated spirit.”<\/p>\n<\/div>\n